CLNN
Clene Inc.NASDAQCONSUMER DEFENSIVEPACKAGED FOODS
Key Statistics
Market Cap
$74.67M
P/E Ratio
—
EPS
$-2.64
Beta
0.62
52W High
$13.50
52W Low
$2.28
50-Day MA
$5.02
200-Day MA
$5.98
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Clene Inc.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.
Fundamentals
| Revenue (TTM) | 200,000 |
| Gross Profit (TTM) | 157,000 |
| EBITDA | $-21.59M |
| Operating Margin | -9734.00% |
| Return on Equity | -1738.00% |
| Return on Assets | -63.50% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $-1.62 |
| Price-to-Book | 7.83 |
| Price-to-Sales (TTM) | 373.37 |
| EV/Revenue | 457.26 |
| EV/EBITDA | -1.13 |
| Quarterly Earnings Growth (YoY) | 61.40% |
| Quarterly Revenue Growth (YoY) | -15.40% |
| Shares Outstanding | $11.78M |
| Float | $8.29M |
| % Insiders | 26.36% |
| % Institutions | 20.04% |
Historical Volatility
HV 10-Day
110.67%
HV 20-Day
104.59%
HV 30-Day
93.74%
HV 60-Day
100.18%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($30.33 target)
1
Strong Buy5
BuyData last updated: 4/10/2026